Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Sees Large Drop in Short Interest

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) was the recipient of a significant decrease in short interest during the month of October. As of October 31st, there was short interest totalling 36,800 shares, a decrease of 8.2% from the October 15th total of 40,100 shares. Based on an average trading volume of 11,400 shares, the short-interest ratio is presently 3.2 days.

Conduit Pharmaceuticals Stock Performance

NASDAQ:CDTTW opened at $0.01 on Tuesday. The firm’s fifty day simple moving average is $0.01 and its 200 day simple moving average is $0.03. Conduit Pharmaceuticals has a twelve month low of $0.01 and a twelve month high of $0.16.

Conduit Pharmaceuticals Company Profile

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.